Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study
General Info
Time period covered
January, 2021 - December, 2021
Data type
Scientific literature
Keywords
Citation
Journal
BMC Public Health
Pages
1031
Publication year
2022
Suggested citation
Zamani M, Poustchi H, Mohammadi Z, Dalvand S, Sharafkhah M, Motevalian SA, Eslami S, Emami A, Somi MH, Yazdani-Charati J, Saki N, Karami M, Najafi F, Mohebbi I, Veisi N, Hormati A, Pourfarzi F, Ghadimi R, Ansari-Moghaddam A, Sharifi H, Roshandel G, Mansour-Ghanaei F, Joukar F, Shayanrad A, Eghtesad S, Niavarani A, Delavari A, Kaveh S, Feizesani A, Markarian M, Shafighian F, Sadjadi A, Darvishian M, Malekzadeh R. Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study. BMC Public Health. 2022; 22(1): 1031.